SCHEMBL5524348

SCHEMBL5524348

CS(=O)(=O)c1ccc(-c2cnc(N(Cc3cc[c]c(Br)c3)c3ccc(Cl)c(Cl)c3)o2)cc1

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 8/20 0.35
PTGS1 P23219 2/20 0.35
FLT1 P17948 1/20 0.31
FLT4 P35916 1/20 0.31
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5507244 0.80 PTGS2 (0.34) PTGS2PTGS1
SCHEMBL5507246 0.80 PTGS2 (0.34) PTGS2PTGS1
SCHEMBL5509364 0.80 PTPN1 (0.43)
SCHEMBL5503559 0.78 PTPN1 (0.41) PTGS2PTGS1
SCHEMBL5504720 0.77 PTPN1 (0.38) PTGS2PTGS1
SCHEMBL5988072 0.77 PTPN5 (0.37) PTGS2PTGS1
SCHEMBL5503199 0.76 PTPN1 (0.34)
SCHEMBL5503895 0.76 PTPN1 (0.37) FLT1FLT4KDR
SCHEMBL5500769 0.75 PTPN1 (0.37) PTGS2
SCHEMBL5503231 0.73 PTPN1 (0.36) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786421-A2 OXYGEN/NITROGEN HETEROCYCLE INHIBITORS OF TYROSINE PHOSPHATASES Cengent Therapeutics, Inc. (US) 2007-05-23 EP disclosed
WO-2006017124-A2 OXYGEN/NITROGEN HETEROCYCLE INHIBITORS OF TYROSINE PHOSPHATASES CENGENT THERAPEUTICS, INC. (US) 2006-02-16 WO disclosed